Concepedia

Author

R D Christen

University of California San Diego

Also Known As

R CHRISTEN, R Christen, R D Christen, R. Christen, RD Christen, Randolph Christen, Randolph D Christen, Randolph D. Christen

55

Publications

3.9K

Citations

28

H-Index

61

Concepts

All Affiliations

University of California San DiegoRoche (Switzerland)Roche Pharma AG (Germany)Roche (United Kingdom)Institut Claudius Regaud
RD

About

R D Christen is an author at University of California San Diego specializing in medicine, cell biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

24

2.7K

2

Cell Biology

17

17

2K

3

Health Sciences

2

2

37

4

Engineering

1

1

23

5

Cellular Physiology

1

1

54

R D Christen

×

42

Publications

3.8K

Citations

27

H-Index

YearCitations

The role of DNA mismatch repair in platinum drug resistance.

Daniel Fink, S Nebel, Stefan Aebi,

PubMed

1996

603

Loss of DNA mismatch repair in acquired resistance to cisplatin.

Stefan Aebi, Buran Kurdi-Haidar, Robert T. Gordon,

PubMed

1996

504

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca,

The Lancet Oncology

2015

356

In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.

Daniel Fink, Hongtu Zheng, S Nebel,

PubMed

1997

278

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages

C. Gomez-Roca, Antoîne Italiano, Christophe Le Tourneau,

Annals of Oncology

2019

189

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen,

Oncotarget

2016

148

Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.

A Nehmé, Rathinasamy Baskaran, Stefan Aebi,

PubMed

1997

130

Identification of Genes That Mediate Sensitivity to Cisplatin

H Niedner, R D Christen, Xian Lin,

Molecular Pharmacology

2001

125

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells

A Nehmé, Rathinasamy Baskaran, S Nebel,

British Journal of Cancer

1999

108

P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.

Xinjian Lin, K Ramamurthi, Misako Mishima,

PubMed

2001

105

Page 1